131 related articles for article (PubMed ID: 31140613)
1. Prognostic significance of peripheral blood-derived neutrophil/lymphocyte ratio in patients with digestive cancer.
Liu F; Luo H; Zhu Z; Zhu P; Huang J
J Cell Physiol; 2019 Dec; 234(12):22775-22786. PubMed ID: 31140613
[TBL] [Abstract][Full Text] [Related]
2. Baseline derived neutrophil-to-lymphocyte ratio as a prognostic biomarker for non-colorectal gastrointestinal cancer patients treated with immune checkpoint blockade.
Li S; Zou J; Liu C; Jiao X; Gong J; Li J; Wang Z; Lu M; Lu Z; Shen L
Clin Immunol; 2020 Mar; 212():108345. PubMed ID: 31953149
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis.
Yang T; Hao L; Yang X; Luo C; Wang G; Lin Cai C; Qi S; Li Z
BMJ Open; 2021 Sep; 11(9):e049123. PubMed ID: 34475167
[TBL] [Abstract][Full Text] [Related]
4. Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.
Ferrucci PF; Ascierto PA; Pigozzo J; Del Vecchio M; Maio M; Antonini Cappellini GC; Guidoboni M; Queirolo P; Savoia P; Mandalà M; Simeone E; Valpione S; Altomonte M; Spagnolo F; Cocorocchio E; Gandini S; Giannarelli D; Martinoli C
Ann Oncol; 2016 Apr; 27(4):732-8. PubMed ID: 26802161
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of pretreatment derived neutrophil to lymphocyte ratio in urological cancers: A systematic review and meta-analysis.
Su S; Liu L; Li C; Zhang J; Li S
Int J Surg; 2019 Dec; 72():146-153. PubMed ID: 31707011
[TBL] [Abstract][Full Text] [Related]
6. The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.
Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
Tumour Biol; 2016 Jan; 37(1):361-8. PubMed ID: 26219894
[TBL] [Abstract][Full Text] [Related]
7. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
Capone M; Giannarelli D; Mallardo D; Madonna G; Festino L; Grimaldi AM; Vanella V; Simeone E; Paone M; Palmieri G; Cavalcanti E; Caracò C; Ascierto PA
J Immunother Cancer; 2018 Jul; 6(1):74. PubMed ID: 30012216
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy.
Templeton AJ; Rodríguez-Lescure Á; Ruíz A; Alba E; Calvo L; Ruíz-Borrego M; Santaballa A; Rodríguez CA; Crespo C; Ramos M; Gracia-Marco JM; Lluch A; Álvarez I; Casas MI; Sánchez-Aragó M; Caballero R; Carrasco E; Amir E; Martin M; Ocaña A;
Clin Transl Oncol; 2018 Dec; 20(12):1548-1556. PubMed ID: 29766456
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.
Yang JJ; Hu ZG; Shi WX; Deng T; He SQ; Yuan SG
World J Gastroenterol; 2015 Mar; 21(9):2807-15. PubMed ID: 25759553
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of preoperative derived neutrophil-to-lymphocyte ratio in patients undergoing total laryngectomy with laryngeal carcinoma.
Song S; Chen H; Dong W; Zhou H
Acta Otolaryngol; 2019 Mar; 139(3):294-298. PubMed ID: 30882257
[TBL] [Abstract][Full Text] [Related]
12. Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study.
Grenader T; Nash S; Adams R; Kaplan R; Fisher D; Maughan T; Bridgewater J
Br J Cancer; 2016 Mar; 114(6):612-5. PubMed ID: 26889974
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.
Zhou X; Sun X; Zhao W; Fang X; Wang X
Cancer Manag Res; 2019; 11():4243-4254. PubMed ID: 31190991
[No Abstract] [Full Text] [Related]
14. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S
World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479
[TBL] [Abstract][Full Text] [Related]
15. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients.
Absenger G; Szkandera J; Pichler M; Stotz M; Arminger F; Weissmueller M; Schaberl-Moser R; Samonigg H; Stojakovic T; Gerger A
Br J Cancer; 2013 Jul; 109(2):395-400. PubMed ID: 23820252
[TBL] [Abstract][Full Text] [Related]
16. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma.
Lee GW; Park SW; Go SI; Kim HG; Kim MK; Min CK; Kwak JY; Bae SB; Yoon SS; Lee JJ; Kim KH; Nam SH; Mun YC; Kim HJ; Bae SH; Shin HJ; Lee JH; Park JS; Jeong SH; Lee MH; Lee HS; Park KW; Lee WS; Lee SM; Lee JO; Hyun MS; Jo DY; Lim SN; Lee JH; Kim H; Cho DY; Do YR; Kim JA; Park SK; Kim JS; Kim SJ; Yi HG; Moon JH; Choi CW; Kim SH; Kim BS; Park MR; Shim H; Song MK; Kim Y; Kim K
Acta Haematol; 2018; 140(3):146-156. PubMed ID: 30253397
[TBL] [Abstract][Full Text] [Related]
17. The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients.
Szkandera J; Gerger A; Liegl-Atzwanger B; Stotz M; Samonigg H; Friesenbichler J; Stojakovic T; Leithner A; Pichler M
Am J Surg; 2015 Jul; 210(1):111-6. PubMed ID: 25586599
[TBL] [Abstract][Full Text] [Related]
18. The derived neutrophil-lymphocyte ratio and the neutrophil-lymphocyte ratio are related to poor prognosis in Hodgkin lymphoma patients.
Shen QQ; Gao J; Tao H; Wang ST; Wang FJ; Chen YY; Zhang X; Jia YQ
Am J Blood Res; 2021; 11(1):100-110. PubMed ID: 33796397
[TBL] [Abstract][Full Text] [Related]
19. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
20. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.
Proctor MJ; McMillan DC; Morrison DS; Fletcher CD; Horgan PG; Clarke SJ
Br J Cancer; 2012 Aug; 107(4):695-9. PubMed ID: 22828611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
